Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Nondiscrimination Bill Marked Up in House of Representatives

NEW YORK (GenomeWeb News) — The Genetic Information Nondiscrimination Act, previously stalled in the US Congress for more than a decade, was marked up in the House of Representatives for the first time yesterday.
 
The bill, known as GINA, was introduced in the House 12 years ago by Rep. Louise Slaughter. Political opposition had prevented it from ever coming to a vote in the House, even though it had been unanimously approved by the Senate on two separate occasions.
 
“Today's action is the first time a House Committee has marked up genetic nondiscrimination legislation,” Slaughter said in a statement. The bill was marked up by the House Committee on Education and Labor.
 
The bill, also known as H.R. 493, aims to bar insurance companies and employers from discriminating against people based on genetic information. It must still be considered in the Energy and Commerce Committees and the Ways and Means Committee.
 
GINA was re-introduced to the House on Jan. 16 by Slaughter, a Democrat from New York, and Rep. Judy Biggert, a Republican from Illinois. Around 150 representatives co-sponsored the bill. 
 
According to Slaughter and Biggert, GINA will make it illegal for group health insurers to deny coverage to healthy people based “solely on a genetic predisposition to a specific disease,” and will forbid employers from using genetic information “when making hiring, firing, job placement or promotion decisions.”
 
In a Democratically controlled Congress the bill appears to have improved chances for getting passed. The measure has garnered broad popular support, has the Bush Administration’s backing, and is supported by a majority of genetic counselors.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.